Sanofi expects Zantac arbitration case with Boehringer Ingelheim to be resolved early this year
After years of Zantac heartburn medication legal action, French pharma Sanofi is seeing a resolution to at least some of the litigation.
In Q4 …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
